Patent: 10,406,278
✉ Email this page to a colleague
Summary for Patent: 10,406,278
Title: | Unified drug mixer and dispenser |
Abstract: | A unified dispenser for holding, mixing, and dispensing a drug includes a housing holding a diluent reservoir, a drug reservoir, and a tubing set connecting and defining a fluid communication path therebetween. A first occlusion is at the diluent reservoir, and a second occlusion is at the drug reservoir. In a storage state of the dispenser, the first and second occlusions are entirely encased within the housing and occlude the fluid communication path. First and second pull assemblies extend outside the housing. The first and second pull assemblies are coupled to the first and second occlusions, respectively, so that removal of the first and second pull assemblies removes the first and second occlusions and joins the diluent reservoir to the drug reservoir in fluid communication through the tubing set, thereby arranging the dispenser from the storage state to a use state. |
Inventor(s): | McNall, III; Ralph I. (Belmont, CA), Donze; Thomas T. (San Bruno, CA), MacDonell; Andrew M. (San Francisco, CA), Joshi; Serena (San Francisco, CA) |
Assignee: | |
Application Number: | 15/687,393 |
Patent Claims: | see list of patent claims |
Details for Patent 10,406,278
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Pfizer Inc. | ELELYSO | taliglucerase alfa | For Injection | 022458 | 05/01/2012 | ⤷ Try a Trial | 2036-02-11 |
Takeda Pharmaceuticals U.s.a., Inc. | VPRIV | velaglucerase alfa | For Injection | 022575 | 02/26/2010 | ⤷ Try a Trial | 2036-02-11 |
Recordati Rare Diseases, Inc. | PANHEMATIN | hemin for injection | For Injection | 101246 | 07/20/1983 | ⤷ Try a Trial | 2036-02-11 |
Amgen, Inc. | NEUPOGEN | filgrastim | Injection | 103353 | 02/20/1991 | ⤷ Try a Trial | 2036-02-11 |
Amgen, Inc. | NEUPOGEN | filgrastim | Injection | 103353 | 06/28/2000 | ⤷ Try a Trial | 2036-02-11 |
Partner Therapeutics, Inc. | LEUKINE | sargramostim | For Injection | 103362 | 03/05/1991 | ⤷ Try a Trial | 2036-02-11 |
Partner Therapeutics, Inc. | LEUKINE | sargramostim | Injection | 103362 | 03/05/1991 | ⤷ Try a Trial | 2036-02-11 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |